Market Tracker

07/24 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

13.72
Data as of Jul 24
 +0.24 / +1.78%
Today’s Change
4.55
Today|||52-Week Range
19.11
+69.80%
Year-to-Date

Today’s Trading

Previous close13.48
Today’s open13.59
Day’s range13.48 - 13.99
Volume195,931
Average volume (3 months)254,223
Market cap$295.3M
Dividend yield--
Data as of 4:00pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-31.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.38+2.64%
OXFDOxford Immunotec Glo...+0.40+2.55%
DNDNDendreon Corp+0.02+0.92%
TTHITransition Therapeut...0.000.00%
Data as of 4:00pm ET, 07/24/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts